Alan Barge
Direttore/Membro del Consiglio presso THERACRYF PLC
Posizioni attive di Alan Barge
Società | Posizione | Inizio | Fine |
---|---|---|---|
THERACRYF PLC | Direttore/Membro del Consiglio | 21/10/2015 | - |
Independent Dir/Board Member | 21/10/2015 | - | |
West Thorpe (2011) Ltd. | Direttore/Membro del Consiglio | - | - |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Direttore degli Investimenti | - | - | |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Investitore di Private Equity | 01/03/2019 | - |
Storia della carriera di Alan Barge
Precedenti posizioni note di Alan Barge
Società | Posizione | Inizio | Fine |
---|---|---|---|
BERGENBIO ASA | Direttore Tecnico/Scientifico/R&S | 22/11/2018 | 13/03/2019 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/07/2009 | 01/12/2010 |
AMGEN INC. | Corporate Officer/Principal | 01/06/1990 | 01/09/1998 |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Presidente | 19/12/2018 | - |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Direttore Tecnico/Scientifico/R&S | - | - |
Fondatore | 01/01/2016 | - | |
Corporate Officer/Principal | 01/01/2016 | - |
Formazione di Alan Barge
University of Oxford | Graduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Stati Uniti | 2 |
Norvegia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 7 |
Health Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
AMGEN INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
THERACRYF PLC | Health Services |
BERGENBIO ASA | Health Technology |
Aziende private | 5 |
---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
West Thorpe (2011) Ltd. | |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Alan Barge
- Esperienza